首页> 外文会议>Biennial Conference of the Australasian Pig Science Association >The Immune Response to a Ten-Times Oral or Intramuscular Immunisation With Lawsonia Vaccine in Weaner Pigs
【24h】

The Immune Response to a Ten-Times Oral or Intramuscular Immunisation With Lawsonia Vaccine in Weaner Pigs

机译:对Weaner Pigs律师疫苗的10倍口服或肌肉内免疫的免疫反应

获取原文

摘要

Proliferative enteropathy (PE) is an important economic disease of pigs, and is caused by the intracellular Gram-negative bacterium Lawsonia intracellularis. PE affects pigs of all ages, causing haemorrhagic enteropathy and death in the acute form orweight loss and diarrhoea in the chronic form. Clinical signs of PE can be controlled with a live oral commercial vaccine (Enterisol* Ileitis, Boehringer Ingelheim Pty Ltd, North Ryde, NSW; Kroll et al., 2004) and a L.intracelluLaris bacterin vaccine administered intramuscularly (Dale et al., 1997). This research ultimately aims to identify an immune marker for protection against PE following vaccination to ensure life-long immunity to PE. This pilot experiment compared the systemic and mucosal immune responses to a ten times (lOx) dose of the Enterisol* Ileitis vaccine given orally or intramuscularly (IM), as previous studies indicated that serum antibodies were not detected following a single vaccine dose (105'5TCID50 L. intracellularis-, Kroll et al., 2004).
机译:增殖性肠病(PE)是猪的重要经济疾病,是由细胞内革兰氏阴性细菌律绘制的细胞外患者。 PE影响所有年龄段的猪,在慢性形式中造成急性形式的急性损失和腹泻的出血性肠球病和死亡。 PE的临床迹象可以用实时口服商业疫苗(Entisisol * eNtleit,Boehringer Ingelheim Pty Ltd,North Ryde,NSW; Kroll等,2004)和肌肉内克林菌疫苗(Dale等, 1997)。该研究最终旨在鉴定免疫标记物,以防止PE免受疫苗接种,以确保终生免疫PE。该试验实验将全身和粘膜免疫应答与口服或肌肉内(IM)给予的10次(LOX)剂量的肠溶剂*对肠炎疫苗(IM)进行了比较,因为之前的研究表明,在单个疫苗剂量(105'时未检测到血清抗体(105' 5TCID50L.Storalellularis-,Kroll等,2004)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号